Apogee Therapeutics, Inc. (NASDAQ: APGE) on Tuesday shared interim data from the Phase 1b trial of zumilokibart (APG777) in patients with mild-to-moderate asthma. The data covers 19 adult patients ...
Dr. Marc Cromie with the Chattanooga Allergy Clinic joins News 12’s Chip Chapman at the start of the New Year with some health tips.  CHATTANOOGA, Tenn. (WDEF) – Flu season is here but best not to ...
More than 24 million Americans have been diagnosed with asthma, and 10 percent of them have a tough time controlling it, even with treatment. But a new form of therapy -- known as biologic -- is ...
Chinese scientists have developed a groundbreaking cell therapy that could provide long-term relief for asthma patients with just a single shot. This new treatment, which has shown promising results ...
Quick-relief meds, also called rescue or short-acting drugs, are just what they sound like an 11th-hour Hail Mary when an asthma attack kicks in. “Whereas long-term and control medications treat ...
A new study shows that internet-delivered cognitive behavioral therapy (ICBT) can effectively reduce asthma-related anxiety ...
Objective Anxiety affects up to one-third of adults with asthma and is linked to poorer disease outcomes and reduced quality ...
Tony Cook runs up to 7 miles a day, but until recently, his severe asthma made it too painful for him to work out for very long. “It feels like a coil is just tightening around your lungs and you ...
Current asthma treatments don't work in all patients, and they don't provide long-term relief from potentially deadly asthma attacks. Scientists at La Jolla Institute for Immunology (LJI) are ...
Asthma is a respiratory condition caused by inflammation and constriction (narrowing) of the airways. It can cause symptoms such as shortness of breath, coughing, or wheezing. Asthma is a long-term ...
This summer’s family barbecue was supposed to be a celebration of sorts—coming together for the first time since the pandemic pulled the plug on group activities. But your joy was cut short by an ...